Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Colon Cancer”

683 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 683 results

Testing effectiveness (Phase 2)Study completedNCT00022477
What this trial is testing

BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Chicago 24
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT04017650
What this trial is testing

Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer

Who this might be right for
BRAF NP_004324.2:p.V600EMetastatic Colon AdenocarcinomaMetastatic Microsatellite Stable Colorectal Carcinoma+13 more
M.D. Anderson Cancer Center 38
Large-scale testing (Phase 3)UnknownNCT00006468
What this trial is testing

Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Looking for participantsNCT06349590
What this trial is testing

Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery

Who this might be right for
Colorectal Cancer
University of Chicago 80
Early research (Phase 1)Study completedNCT00155558
What this trial is testing

A Phase I Trial of HDFL48 in Recurrent or Metastatic Colorectal Cancers

Who this might be right for
Recurrent or Metastatic Colorectal Cancer
National Taiwan University Hospital 16
Testing effectiveness (Phase 2)Study completedNCT01814501
What this trial is testing

Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+5 more
John Hays 16
Testing effectiveness (Phase 2)UnknownNCT01110785
What this trial is testing

Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Leiden University Medical Center 46
Post-approval studies (Phase 4)UnknownNCT04810585
What this trial is testing

Plasma Biomarker for Aflibercept in Advanced Colorectal Cancer

Who this might be right for
Recurrent or Metastatic Colorectal Cancer
Yonsei University 153
Not applicableActive Not RecruitingNCT04065984
What this trial is testing

Body Composition Manipulation in CoLorectal cancEr (BiCyCLE): Neuromuscular Electrical Stimulation (NMES)

Who this might be right for
Rectal CancerColorectal CancerColon Cancer+5 more
London North West Healthcare NHS Trust 46
Testing effectiveness (Phase 2)Study completedNCT00003225
What this trial is testing

Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jonsson Comprehensive Cancer Center 23
Not applicableStudy completedNCT01789749
What this trial is testing

Soft Coagulation for the Prevention of Adenoma Recurrence

Who this might be right for
Colonic Adenomas
Professor Michael Bourke 455
Testing effectiveness (Phase 2)Study completedNCT00290615
What this trial is testing

Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Herbert Hurwitz 30
Testing effectiveness (Phase 2)Study completedNCT00556413
What this trial is testing

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 42
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Early research (Phase 1)Ended earlyNCT07121829
What this trial is testing

Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors

Who this might be right for
MelanomaSolid TumorPilocytic Astrocytoma+7 more
Day One Biopharmaceuticals, Inc. 44
Testing effectiveness (Phase 2)Study completedNCT00077337
What this trial is testing

FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
SWOG Cancer Research Network
Testing effectiveness (Phase 2)UnknownNCT00303745
What this trial is testing

Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 78
Testing effectiveness (Phase 2)Study completedNCT00055822
What this trial is testing

Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
The University of Texas Health Science Center at San Antonio 16
Not applicableLooking for participantsNCT06629051
What this trial is testing

6-year Follow-up Data After the Berberine Intervention Trial

Who this might be right for
Colorectal AdenomaColorectal Cancer Control and PreventionColorectal Polyps
Shanghai Jiao Tong University School of Medicine 891
Load More Results